BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 28009106)

  • 21. Post hoc analysis of fecal samples from responders and non-responders to Lactobacillus reuteri DSM 17938 intervention.
    Szymanski H; Mlynarz P; Qasem B; Korzeniowska-Kowal A; Szponar B; Kałwak-Baran M; Szajewska H
    Acta Biochim Pol; 2020 Sep; 67(3):393-399. PubMed ID: 32945647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lactobacillus reuteri supplements do not affect salivary IgA or cytokine levels in healthy subjects: A randomized, double-blind, placebo-controlled, cross-over trial.
    Jørgensen MR; Keller MK; Kragelund C; Hamberg K; Ericson D; Nielsen CH; Twetman S
    Acta Odontol Scand; 2016 Jul; 74(5):399-404. PubMed ID: 27104984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Lactobacillus reuteri colonization on gut microbiota, inflammation, and crying time in infant colic.
    Nation ML; Dunne EM; Joseph SJ; Mensah FK; Sung V; Satzke C; Tang MLK
    Sci Rep; 2017 Nov; 7(1):15047. PubMed ID: 29118383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotic supplementation in systemic nickel allergy syndrome patients: study of its effects on lactic acid bacteria population and on clinical symptoms.
    Randazzo CL; Pino A; Ricciardi L; Romano C; Comito D; Arena E; Saitta S; Caggia C
    J Appl Microbiol; 2015 Jan; 118(1):202-11. PubMed ID: 25363062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of probiotics and synbiotic supplementation on glucose and insulin metabolism in adults with prediabetes: a double-blind randomized clinical trial.
    Kassaian N; Feizi A; Aminorroaya A; Jafari P; Ebrahimi MT; Amini M
    Acta Diabetol; 2018 Oct; 55(10):1019-1028. PubMed ID: 29931423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of the prenatal administration of Lactobacillus reuteri LR92 DSM 26866 on the prevention of infantile colic: a randomized control trial.
    Pourmirzaiee MA; Famouri F; Moazeni W; Hassanzadeh A; Hajihashemi M
    Eur J Pediatr; 2020 Oct; 179(10):1619-1626. PubMed ID: 32372186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lactobacillus reuteri DSM 17938 and Magnesium Oxide in Children with Functional Chronic Constipation: A Double-Blind and Randomized Clinical Trial.
    Kubota M; Ito K; Tomimoto K; Kanazaki M; Tsukiyama K; Kubota A; Kuroki H; Fujita M; Vandenplas Y
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31952280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lactobacillus reuteri improves the development and maturation of fecal microbiota in piglets through mother-to-infant microbe and metabolite vertical transmission.
    Wang G; Wang X; Ma Y; Cai S; Yang L; Fan Y; Zeng X; Qiao S
    Microbiome; 2022 Dec; 10(1):211. PubMed ID: 36461096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in bile acids, FGF-19 and sterol absorption in response to bile salt hydrolase active L. reuteri NCIMB 30242.
    Martoni CJ; Labbé A; Ganopolsky JG; Prakash S; Jones ML
    Gut Microbes; 2015; 6(1):57-65. PubMed ID: 25612224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial.
    Savino F; Cordisco L; Tarasco V; Palumeri E; Calabrese R; Oggero R; Roos S; Matteuzzi D
    Pediatrics; 2010 Sep; 126(3):e526-33. PubMed ID: 20713478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of Lactobacillus reuteri DSM17938 in the human intestinal tract: response to consecutive and alternate-day supplementation.
    Smith TJ; Anderson D; Margolis LM; Sikes A; Young AJ
    J Am Coll Nutr; 2011 Aug; 30(4):259-64. PubMed ID: 21917706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative evaluation of probiotics effects on plasma glucose, lipid, and insulin levels in streptozotocin-induced diabetic rats.
    Memarrast F; Ghafouri-Fard S; Kolivand S; Nodooshan SJ; Neyazi N; Sadroddiny E; Motevaseli E
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28608654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant Probiotics of
    Wang CH; Yen HR; Lu WL; Ho HH; Lin WY; Kuo YW; Huang YY; Tsai SY; Lin HC
    Front Endocrinol (Lausanne); 2022; 13():754401. PubMed ID: 35299968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial.
    Heise T; Mari A; DeVries JH; Urva S; Li J; Pratt EJ; Coskun T; Thomas MK; Mather KJ; Haupt A; Milicevic Z
    Lancet Diabetes Endocrinol; 2022 Jun; 10(6):418-429. PubMed ID: 35468322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supplementation of α-linolenic acid improves serum adiponectin levels and insulin sensitivity in patients with type 2 diabetes.
    Gomes PM; Hollanda-Miranda WR; Beraldo RA; Castro AV; Geloneze B; Foss MC; Foss-Freitas MC
    Nutrition; 2015 Jun; 31(6):853-7. PubMed ID: 25933493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of lixisenatide in a predominantly Asian population with type 2 diabetes insufficiently controlled with basal insulin: The GetGoal-L-C randomized trial.
    Yang W; Min K; Zhou Z; Li L; Xu X; Zhu D; Venkateshwar Rao A; Murthy LS; Zhang N; Li I; Niemoeller E; Shang S
    Diabetes Obes Metab; 2018 Feb; 20(2):335-343. PubMed ID: 28742225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE): A double-blind, randomized, placebo-controlled clinical trial.
    Moreira-Lucas TS; Duncan AM; Rabasa-Lhoret R; Vieth R; Gibbs AL; Badawi A; Wolever TM
    Diabetes Obes Metab; 2017 Jan; 19(1):133-141. PubMed ID: 27717236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation.
    Wang ZQ; Qin J; Martin J; Zhang XH; Sereda O; Anderson RA; Pinsonat P; Cefalu WT
    Metabolism; 2007 Dec; 56(12):1652-5. PubMed ID: 17998017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of Lactobacillus reuteri DSM 17938 for the Prevention of Nosocomial Diarrhea in Children: A Randomized, Double-blind, Placebo-controlled Trial.
    Urbańska M; Gieruszczak-Białek D; Szymański H; Szajewska H
    Pediatr Infect Dis J; 2016 Feb; 35(2):142-5. PubMed ID: 26551445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventive effects of oral probiotic on infantile colic: a prospective, randomised, blinded, controlled trial using Lactobacillus reuteri DSM 17938.
    Savino F; Ceratto S; Poggi E; Cartosio ME; Cordero di Montezemolo L; Giannattasio A
    Benef Microbes; 2015; 6(3):245-51. PubMed ID: 25488262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.